Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease

Robert Nisticò, S. Piccinin, C. Schepisi, C. Ferraina, M. Laurenza, D. Mango, M. Graziani, F. Nicoletti, N. B. Mercuri, M. Feligioni

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The discovery of long-term potentiation (LTP) of hippocampal synaptic transmission, which represents a classical model for learning and memory at the cellular level, has stimulated over the past years substantial progress in the understanding of pathogenic mechanisms underlying cognitive disorders, such as Alzheimer's disease (AD). Multiple lines of evidence indicate synaptic dysfunction not only as a core feature but also a leading cause of AD. Multiple pathways may play a significant role in the execution of synaptic dysfunction and neuronal death triggered by beta-amyloid (Aβ) in AD. Following intensive investigations into LTP in AD models, a variety of compounds have been found to rescue LTP impairment via numerous molecular mechanisms. Yet very few of these findings have been successfully translated into disease-modifying compounds in humans. This review recapitulates the emerging disease-modifying strategies utilized to modulate hippocampal synaptic plasticity with particular attention to approaches targeting ligand-gated ion channels, G-protein-coupled receptors (GPCRs), Receptor Tyrosine Kinases (RTKs) and epigenetic mechanisms. It is hoped that novel multi-targeted drugs capable of regulating spine plasticity might be effective to counteract the progression of AD and related cognitive syndromes.

Original languageEnglish
Pages (from-to)37-47
Number of pages11
JournalJournal of Biological Regulators and Homeostatic Agents
Volume27
Issue number2 SUPPL.
Publication statusPublished - Apr 2013

Fingerprint

Long-Term Potentiation
Alzheimer Disease
Animal Models
Pharmacology
Ligand-Gated Ion Channels
Neuronal Plasticity
Receptor Protein-Tyrosine Kinases
G-Protein-Coupled Receptors
Amyloid
Epigenomics
Synaptic Transmission
Spine
Learning
Pharmaceutical Preparations

Keywords

  • Alzheimer's disease
  • Hippocampus
  • Long-term potentiation
  • Synaptic plasticity

ASJC Scopus subject areas

  • Oncology
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)
  • Immunology and Allergy
  • Immunology
  • Endocrinology
  • Physiology
  • Cancer Research

Cite this

Nisticò, R., Piccinin, S., Schepisi, C., Ferraina, C., Laurenza, M., Mango, D., ... Feligioni, M. (2013). Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease. Journal of Biological Regulators and Homeostatic Agents, 27(2 SUPPL.), 37-47.

Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease. / Nisticò, Robert; Piccinin, S.; Schepisi, C.; Ferraina, C.; Laurenza, M.; Mango, D.; Graziani, M.; Nicoletti, F.; Mercuri, N. B.; Feligioni, M.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 27, No. 2 SUPPL., 04.2013, p. 37-47.

Research output: Contribution to journalArticle

Nisticò, R, Piccinin, S, Schepisi, C, Ferraina, C, Laurenza, M, Mango, D, Graziani, M, Nicoletti, F, Mercuri, NB & Feligioni, M 2013, 'Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease', Journal of Biological Regulators and Homeostatic Agents, vol. 27, no. 2 SUPPL., pp. 37-47.
Nisticò R, Piccinin S, Schepisi C, Ferraina C, Laurenza M, Mango D et al. Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease. Journal of Biological Regulators and Homeostatic Agents. 2013 Apr;27(2 SUPPL.):37-47.
Nisticò, Robert ; Piccinin, S. ; Schepisi, C. ; Ferraina, C. ; Laurenza, M. ; Mango, D. ; Graziani, M. ; Nicoletti, F. ; Mercuri, N. B. ; Feligioni, M. / Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease. In: Journal of Biological Regulators and Homeostatic Agents. 2013 ; Vol. 27, No. 2 SUPPL. pp. 37-47.
@article{6f0250ef198e4879ad9c17cacdee6d22,
title = "Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease",
abstract = "The discovery of long-term potentiation (LTP) of hippocampal synaptic transmission, which represents a classical model for learning and memory at the cellular level, has stimulated over the past years substantial progress in the understanding of pathogenic mechanisms underlying cognitive disorders, such as Alzheimer's disease (AD). Multiple lines of evidence indicate synaptic dysfunction not only as a core feature but also a leading cause of AD. Multiple pathways may play a significant role in the execution of synaptic dysfunction and neuronal death triggered by beta-amyloid (Aβ) in AD. Following intensive investigations into LTP in AD models, a variety of compounds have been found to rescue LTP impairment via numerous molecular mechanisms. Yet very few of these findings have been successfully translated into disease-modifying compounds in humans. This review recapitulates the emerging disease-modifying strategies utilized to modulate hippocampal synaptic plasticity with particular attention to approaches targeting ligand-gated ion channels, G-protein-coupled receptors (GPCRs), Receptor Tyrosine Kinases (RTKs) and epigenetic mechanisms. It is hoped that novel multi-targeted drugs capable of regulating spine plasticity might be effective to counteract the progression of AD and related cognitive syndromes.",
keywords = "Alzheimer's disease, Hippocampus, Long-term potentiation, Synaptic plasticity",
author = "Robert Nistic{\`o} and S. Piccinin and C. Schepisi and C. Ferraina and M. Laurenza and D. Mango and M. Graziani and F. Nicoletti and Mercuri, {N. B.} and M. Feligioni",
year = "2013",
month = "4",
language = "English",
volume = "27",
pages = "37--47",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease

AU - Nisticò, Robert

AU - Piccinin, S.

AU - Schepisi, C.

AU - Ferraina, C.

AU - Laurenza, M.

AU - Mango, D.

AU - Graziani, M.

AU - Nicoletti, F.

AU - Mercuri, N. B.

AU - Feligioni, M.

PY - 2013/4

Y1 - 2013/4

N2 - The discovery of long-term potentiation (LTP) of hippocampal synaptic transmission, which represents a classical model for learning and memory at the cellular level, has stimulated over the past years substantial progress in the understanding of pathogenic mechanisms underlying cognitive disorders, such as Alzheimer's disease (AD). Multiple lines of evidence indicate synaptic dysfunction not only as a core feature but also a leading cause of AD. Multiple pathways may play a significant role in the execution of synaptic dysfunction and neuronal death triggered by beta-amyloid (Aβ) in AD. Following intensive investigations into LTP in AD models, a variety of compounds have been found to rescue LTP impairment via numerous molecular mechanisms. Yet very few of these findings have been successfully translated into disease-modifying compounds in humans. This review recapitulates the emerging disease-modifying strategies utilized to modulate hippocampal synaptic plasticity with particular attention to approaches targeting ligand-gated ion channels, G-protein-coupled receptors (GPCRs), Receptor Tyrosine Kinases (RTKs) and epigenetic mechanisms. It is hoped that novel multi-targeted drugs capable of regulating spine plasticity might be effective to counteract the progression of AD and related cognitive syndromes.

AB - The discovery of long-term potentiation (LTP) of hippocampal synaptic transmission, which represents a classical model for learning and memory at the cellular level, has stimulated over the past years substantial progress in the understanding of pathogenic mechanisms underlying cognitive disorders, such as Alzheimer's disease (AD). Multiple lines of evidence indicate synaptic dysfunction not only as a core feature but also a leading cause of AD. Multiple pathways may play a significant role in the execution of synaptic dysfunction and neuronal death triggered by beta-amyloid (Aβ) in AD. Following intensive investigations into LTP in AD models, a variety of compounds have been found to rescue LTP impairment via numerous molecular mechanisms. Yet very few of these findings have been successfully translated into disease-modifying compounds in humans. This review recapitulates the emerging disease-modifying strategies utilized to modulate hippocampal synaptic plasticity with particular attention to approaches targeting ligand-gated ion channels, G-protein-coupled receptors (GPCRs), Receptor Tyrosine Kinases (RTKs) and epigenetic mechanisms. It is hoped that novel multi-targeted drugs capable of regulating spine plasticity might be effective to counteract the progression of AD and related cognitive syndromes.

KW - Alzheimer's disease

KW - Hippocampus

KW - Long-term potentiation

KW - Synaptic plasticity

UR - http://www.scopus.com/inward/record.url?scp=84886774139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886774139&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84886774139

VL - 27

SP - 37

EP - 47

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 2 SUPPL.

ER -